207 related articles for article (PubMed ID: 19197731)
1. Treatment of elderly patients with chronic lymphocytic leukemia.
Eichhorst B; Goede V; Hallek M
Leuk Lymphoma; 2009 Feb; 50(2):171-8. PubMed ID: 19197731
[TBL] [Abstract][Full Text] [Related]
2. Management of elderly and unfit patients with chronic lymphocytic leukemia.
Mauro FR; Salaroli A; Caputo MD; Colafigli G; Petrucci L; Campanelli M; Ferretti A; Guarini AR; Foà R
Expert Rev Hematol; 2016 Dec; 9(12):1165-1175. PubMed ID: 27796157
[TBL] [Abstract][Full Text] [Related]
3. [Chronic lymphocytic leukemia : treatment concepts in transition].
Eichhorst B; Hallek M
Internist (Berl); 2015 Apr; 56(4):374-80. PubMed ID: 25776793
[TBL] [Abstract][Full Text] [Related]
4. The HOVON68 CLL trial revisited: performance status and comorbidity affect survival in elderly patients with chronic lymphocytic leukemia.
Vojdeman FJ; Van't Veer MB; Tjønnfjord GE; Itälä-Remes M; Kimby E; Polliack A; Wu KL; Doorduijn JK; Alemayehu WG; Wittebol S; Kozak T; Walewski J; Abrahamse-Testroote MC; van Oers MH; Geisler CH
Leuk Lymphoma; 2017 Mar; 58(3):594-600. PubMed ID: 27484290
[TBL] [Abstract][Full Text] [Related]
5. State-of-the-Art Treatment and Novel Agents in Chronic Lymphocytic Leukemia.
Cramer P; Hallek M; Eichhorst B
Oncol Res Treat; 2016; 39(1-2):25-32. PubMed ID: 26890007
[TBL] [Abstract][Full Text] [Related]
6. Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) Task Force.
Stauder R; Eichhorst B; Hamaker ME; Kaplanov K; Morrison VA; Österborg A; Poddubnaya I; Woyach JA; Shanafelt T; Smolej L; Ysebaert L; Goede V
Ann Oncol; 2017 Feb; 28(2):218-227. PubMed ID: 27803007
[TBL] [Abstract][Full Text] [Related]
7. Initial therapy of chronic lymphocytic leukemia.
Eichhorst B; Cramer P; Hallek M
Semin Oncol; 2016 Apr; 43(2):241-50. PubMed ID: 27040702
[TBL] [Abstract][Full Text] [Related]
8. [Chronic lymphocytic leukemia].
Maurer C; Hallek M
Dtsch Med Wochenschr; 2013 Oct; 138(42):2153-66. PubMed ID: 24104591
[TBL] [Abstract][Full Text] [Related]
9. Chronic Lymphocytic Leukemia in the Elderly, Which Investigations Are Necessary: A Map for the Practicing Oncologist.
Pinilla-Ibarz J; Emole J
Cancer Control; 2015 Oct; 22(4 Suppl):7-16. PubMed ID: 26618341
[TBL] [Abstract][Full Text] [Related]
10. Impact of active surveillance, chlorambucil, and other therapy on health-related quality of life in patients with CLL/SLL in the Netherlands.
van den Broek EC; Oerlemans S; Nijziel MR; Posthuma EF; Coebergh JW; van de Poll-Franse LV
Ann Hematol; 2015 Jan; 94(1):45-56. PubMed ID: 25038918
[TBL] [Abstract][Full Text] [Related]
11. Treatment approach for elderly and unfit patients with chronic lymphocytic leukemia.
Innocenti I; Autore F; Pasquale R; Morelli F; Efremov DG; Laurenti L
Expert Rev Hematol; 2017 Dec; 10(12):1069-1076. PubMed ID: 29082795
[TBL] [Abstract][Full Text] [Related]
12. Chronic Lymphocytic Leukemia in the Elderly: Epidemiology and Proposed Patient-Related Approach.
Balducci L; Dolan D
Cancer Control; 2015 Oct; 22(4 Suppl):3-6. PubMed ID: 26618340
[TBL] [Abstract][Full Text] [Related]
13. Chlorambucil for the treatment of patients with chronic lymphocytic leukemia (CLL) - a systematic review and meta-analysis of randomized trials.
Vidal L; Gurion R; Ram R; Raanani P; Bairey O; Robak T; Gafter-Gvili A; Shpilberg O
Leuk Lymphoma; 2016 Sep; 57(9):2047-57. PubMed ID: 26980554
[TBL] [Abstract][Full Text] [Related]
14. [Individualized Treatment of Chronic Lymphocytic Leukemia (CLL)].
von Tresckow J; Hallek M; Eichhorst B
Dtsch Med Wochenschr; 2018 Sep; 143(18):1318-1324. PubMed ID: 30199912
[TBL] [Abstract][Full Text] [Related]
15. First-line therapy for chronic lymphocytic leukemia in patients older than 79 years is feasible and achieves good results: A FILO retrospective study.
Meunier G; Ysebaert L; Nguyen-Thi PL; Lepretre S; Quinquenel A; Dupuis J; Lemal R; Aurran T; Tomowiak C; Cymbalista F; Dilhuydy MS; Brion A; Morel P; Cazin B; Leblond V; Cartron G; Ré D; Béné MC; Michallet AS; Feugier P
Hematol Oncol; 2017 Dec; 35(4):671-678. PubMed ID: 27878835
[TBL] [Abstract][Full Text] [Related]
16. Treatment of older patients with chronic lymphocytic leukemia: key questions and current answers.
Shanafelt T
Hematology Am Soc Hematol Educ Program; 2013; 2013():158-67. PubMed ID: 24319177
[TBL] [Abstract][Full Text] [Related]
17. Spotlight on chronic lymphocytic leukemia: a Pharma Matters report.
D'Souza P; Walker G
Drugs Today (Barc); 2014 Jul; 50(7):485-501. PubMed ID: 25101331
[TBL] [Abstract][Full Text] [Related]
18. Chronic lymphocytic leukemia in less fit patients: "slow-go".
Del Giudice I; Mauro FR; Foà R
Leuk Lymphoma; 2011 Dec; 52(12):2207-16. PubMed ID: 21774745
[TBL] [Abstract][Full Text] [Related]
19. Prognostic markers and standard management of chronic lymphocytic leukemia.
Stilgenbauer S
Hematology Am Soc Hematol Educ Program; 2015; 2015():368-77. PubMed ID: 26637745
[TBL] [Abstract][Full Text] [Related]
20. The CLL comorbidity index in a population-based cohort: a tool for clinical care and research.
Rotbain EC; Gordon MJ; Vainer N; Frederiksen H; Hjalgrim H; Danilov AV; Niemann CU
Blood Adv; 2022 Apr; 6(8):2701-2706. PubMed ID: 35008098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
